Genetic Engineering and Biotechnology News reports on early ADMET use

eurekalert.org     May 5, 2008            

Biotech and pharma companies are increasingly utilizing novel technologies to assess the druggability of test compounds early in the development cycle to avoid costly late clinical-stage attrition, according to Genetic Engineering and Biotechnology News. By identifying absorption, distribution,... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics